Literature DB >> 30571225

Diagnostic Thresholds for Blood Pressure Measured at Home in the Context of the 2017 Hypertension Guideline.

Wanpen Vongpatanasin1,2, Colby Ayers2,3, Hamza Lodhi1, Sandeep R Das2, Jarett D Berry2, Amit Khera2, Ronald G Victor4, Feng-Chang Lin5, Anthony J Viera6, Yuichiro Yano6, James A de Lemos2.   

Abstract

Most guidelines have recommended lower home blood pressure (BP) threshold when clinic BP threshold of 140/90 mm Hg is used for diagnosis of hypertension. However, home BP thresholds to define hypertension have never been determined in the general population in the United States. We identified home BP thresholds for stage 1 (BP ≥130/80 mm Hg) hypertension using a regression-based approach in the DHS (Dallas Heart Study; n=5768) and the NCMH study (North Carolina Masked Hypertension; n=420). Home BP thresholds were also assessed using outcome-derived approach based on the composite of all-cause mortality or cardiovascular events in the DHS cohort. For this approach, BP thresholds were identified only for systolic BP because diastolic BP was not associated with the outcome. Among untreated participants, the regression-derived thresholds for home BP corresponding to clinic BP for stage 1 hypertension were 129/80 mm Hg in blacks, 130/80 mm Hg in whites, and 126/78 mm Hg in Hispanics, respectively. The results are similar in the North Carolina cohort. The 11-year composite cardiovascular and mortality events corresponding to clinic systolic BP >130 mm Hg were higher in blacks than in whites and Hispanics (13.3% versus 5.98% versus 5.52%, respectively). Using a race/ethnicity-specific composite outcome in the untreated DHS participants, the outcome-derived home systolic BP thresholds corresponding to stage 1 hypertension were 130 mm Hg in blacks, 129 mm Hg in whites, and 131 mm Hg in Hispanics, respectively. Our data based on both regression-derived and outcome approach support home BP threshold of 130/80 mm Hg for diagnosis of hypertension in blacks, whites, and Hispanics.

Entities:  

Keywords:  United States; blood pressure; blood pressure determination; blood pressure monitors; hypertension; mortality

Mesh:

Year:  2018        PMID: 30571225      PMCID: PMC6309342          DOI: 10.1161/HYPERTENSIONAHA.118.11657

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  29 in total

1.  Validation of the Welch Allyn 'Vital Signs' oscillometric blood pressure monitor.

Authors:  C R Jones; K Taylor; L Poston; A H Shennan
Journal:  J Hum Hypertens       Date:  2001-03       Impact factor: 3.012

2.  Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement.

Authors:  Albert L Siu
Journal:  Ann Intern Med       Date:  2015-10-13       Impact factor: 25.391

3.  Thresholds for Ambulatory Blood Pressure Among African Americans in the Jackson Heart Study.

Authors:  Joseph Ravenell; Daichi Shimbo; John N Booth; Daniel F Sarpong; Charles Agyemang; Danielle L Beatty Moody; Marwah Abdalla; Tanya M Spruill; Amanda J Shallcross; Adam P Bress; Paul Muntner; Gbenga Ogedegbe
Journal:  Circulation       Date:  2017-04-20       Impact factor: 29.690

4.  Reproducibility of masked hypertension among adults 30 years or older.

Authors:  Anthony J Viera; Feng-Chang Lin; Laura A Tuttle; Emily Olsson; Kristin Stankevitz; Susan S Girdler; J Larry Klein; Alan L Hinderliter
Journal:  Blood Press Monit       Date:  2014-08       Impact factor: 1.444

Review 5.  2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Paul K Whelton; Robert M Carey; Wilbert S Aronow; Donald E Casey; Karen J Collins; Cheryl Dennison Himmelfarb; Sondra M DePalma; Samuel Gidding; Kenneth A Jamerson; Daniel W Jones; Eric J MacLaughlin; Paul Muntner; Bruce Ovbiagele; Sidney C Smith; Crystal C Spencer; Randall S Stafford; Sandra J Taler; Randal J Thomas; Kim A Williams; Jeff D Williamson; Jackson T Wright
Journal:  Hypertension       Date:  2017-11-13       Impact factor: 10.190

6.  Prevalence of Masked Hypertension Among US Adults With Nonelevated Clinic Blood Pressure.

Authors:  Y Claire Wang; Daichi Shimbo; Paul Muntner; Andrew E Moran; Lawrence R Krakoff; Joseph E Schwartz
Journal:  Am J Epidemiol       Date:  2017-02-01       Impact factor: 4.897

7.  Racial differences in the impact of elevated systolic blood pressure on stroke risk.

Authors:  George Howard; Daniel T Lackland; Dawn O Kleindorfer; Brett M Kissela; Claudia S Moy; Suzanne E Judd; Monika M Safford; Mary Cushman; Stephen P Glasser; Virginia J Howard
Journal:  JAMA Intern Med       Date:  2013-01-14       Impact factor: 21.873

8.  The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health.

Authors:  Ronald G Victor; Robert W Haley; DuWayne L Willett; Ronald M Peshock; Patrice C Vaeth; David Leonard; Mujeeb Basit; Richard S Cooper; Vincent G Iannacchione; Wendy A Visscher; Jennifer M Staab; Helen H Hobbs
Journal:  Am J Cardiol       Date:  2004-06-15       Impact factor: 2.778

9.  Home blood pressure monitoring and hypertension status among US adults: the National Health and Nutrition Examination Survey (NHANES), 2009-2010.

Authors:  Yechiam Ostchega; Lewis Berman; Jeffery P Hughes; Te-Ching Chen; Michele M Chiappa
Journal:  Am J Hypertens       Date:  2013-04-19       Impact factor: 2.689

10.  Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients.

Authors:  Guillaume Bobrie; Gilles Chatellier; Nathalie Genes; Pierre Clerson; Laurent Vaur; Bernard Vaisse; Joël Menard; Jean-Michel Mallion
Journal:  JAMA       Date:  2004-03-17       Impact factor: 56.272

View more
  5 in total

1.  Out-of-Clinic Blood Pressure Thresholds for Diagnosing and Managing Hypertension, Filling an Important Evidence Gap.

Authors:  Paul Muntner; Daichi Shimbo
Journal:  Hypertension       Date:  2018-12       Impact factor: 10.190

2.  2022 Guidelines of the Taiwan Society of Cardiology and the Taiwan Hypertension Society for the Management of Hypertension.

Authors:  Tzung-Dau Wang; Chern-En Chiang; Ting-Hsing Chao; Hao-Min Cheng; Yen-Wen Wu; Yih-Jer Wu; Yen-Hung Lin; Michael Yu-Chih Chen; Kwo-Chang Ueng; Wei-Ting Chang; Ying-Hsiang Lee; Yu-Chen Wang; Pao-Hsien Chu; Tzu-Fan Chao; Hsien-Li Kao; Charles Jia-Yin Hou; Tsung-Hsien Lin
Journal:  Acta Cardiol Sin       Date:  2022-05       Impact factor: 1.800

3.  Superiority of Out-of-Office Blood Pressure for Predicting Hypertensive Heart Disease in Non-Hispanic Black Adults.

Authors:  Florian Rader; Stanley S Franklin; James Mirocha; Wanpen Vongpatanasin; Robert W Haley; Ronald G Victor
Journal:  Hypertension       Date:  2019-09-16       Impact factor: 10.190

4.  Emergence of Home Blood Pressure-Guided Management of Hypertension Based on Global Evidence.

Authors:  Kazuomi Kario; Daichi Shimbo; Satoshi Hoshide; Ji-Guang Wang; Kei Asayama; Takayoshi Ohkubo; Yutaka Imai; Richard J McManus; Anastasios Kollias; Teemu J Niiranen; Gianfranco Parati; Bryan Williams; Michael A Weber; Wanpen Vongpatanasin; Paul Muntner; George S Stergiou
Journal:  Hypertension       Date:  2019-07-01       Impact factor: 10.190

Review 5.  Resistant hypertension-defining the scope of the problem.

Authors:  Richard Chia; Ambarish Pandey; Wanpen Vongpatanasin
Journal:  Prog Cardiovasc Dis       Date:  2019-12-19       Impact factor: 11.278

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.